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Since the first reported repair of a thoracoab-
dominal aneurysm (TAA) by Etheridge et al1 in
1954, there have been considerable advances in tech-
nique and results. In 1965, Crawford2 introduced
the inclusion technique for repair of these complex
aneurysms, and the mortality and morbidity rates,
particularly for spinal cord ischemia (SCI) and renal
failure, were greatly improved. More recently, the use
of cardiopulmonary perfusion has been advocated by
some authors to improve the early results for exten-
sive group I and group II TAAs.3,4 However, group
III and group IV TAAs, as well as suprarenal
aneurysms (SRAs), usually have been repaired
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Objective: The purpose of this study is to review our experience with surgical repair of
lower thoracoabdominal and suprarenal aortic aneurysms to determine early and late
survival rates and identify factors influencing morbidity and survival among these
patients.
Materials: From 1989 through 1998, 165 consecutive patients underwent repair of 108
thoracoabdominal (55 group III and 53 group IV) and 57 suprarenal aneurysms. The
study group consisted of 109 men and 56 women with a mean age of 70 years (median,
70 years; range, 29-89 years). Mean aneurysm diameter was 6.9 cm (median, 6.5 cm;
range, 4-12 cm). There were 125 aneurysms (76%) repaired electively; 40 repairs (24%)
were nonelective. The cause of 12 aneurysms (7%) was chronic aortic dissection; the
remaining 153 (93%) were degenerative aneurysms.
Results: The early postoperative (30-day) mortality rates were 7% (9/125) for elective
and 23% (9/40) for nonelective operations (P = .016). For both elective and urgent pro-
cedures, early mortality was 1.8% (1/57) for suprarenal aneurysm repair, 11% (6/53)
for group IV thoracoabdominal aneurysms, and 20% (11/55) for group III thoracoab-
dominal aneurysms (P = .013, suprarenal vs group III). Spinal cord ischemia occurred
after 6% (10/165) of aneurysm repairs (4% paraplegia, 2% paraparesis). None of the 57
suprarenal aneurysm repairs were complicated by spinal cord ischemia, whereas it
occurred in 2% (1/53) of group IV thoracoabdominal aneurysms and 16% (9/55) of
group III thoracoabdominal aneurysms (P = .001, suprarenal vs group III; P = .016,
group IV vs group III). Three (25%) of the 12 patients with dissection developed spinal
cord ischemia; this compared with seven (5%) of 153 patients with degenerative
aneurysms (P = .027). The cumulative 3-year survival rate for the entire series was 71%
(95% CI, 64%-79%), and 5-year survival was 50% (95% CI, 40%-60%). 
Conclusions: Aneurysms involving the suprarenal, visceral, and lower thoracic aorta may
be repaired with acceptable perioperative mortality and late survival rates. The risk of
spinal cord ischemia is increased for patients with aortic dissection and may be stratified
according to the proximal extent of the aneurysm. (J Vasc Surg 2000;31:851-62.)
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through the use of the inclusion method without
adjunctive perfusion techniques to avoid the coagu-
lation and cannulation problems associated with car-
diopulmonary bypass. Because these aneurysms are
more likely to be encountered by the vascular sur-
geon, the present study was undertaken to determine
the postoperative mortality and morbidity rates asso-
ciated with the surgical management of group III
and group IV TAAs and SRAs at our own center to
document the late survival rate in these patients and
identify clinical factors that might influence their ulti-
mate outcome. 
PATIENTS AND METHODS
We collected retrospective data from the hospital
records of 165 consecutive patients who were
entered in our departmental registry after receiving
surgical treatment of SRAs or group III or group IV
TAAs at the Cleveland Clinic from January 1989
through December 1998. Long-term information
was obtained during subsequent office visits or by
telephone contact with the patients, their immediate
families, or their local physicians. Group III TAAs
were defined, according to the Crawford classifica-
tion,2 as those involving the entire abdominal and
visceral aorta with proximal extension to involve the
distal descending thoracic aorta. Group IV TAAs
involved the entire abdominal and visceral aorta with
proximal extension to the diaphragm and required
supraceliac aortic clamping. The SRAs directly
involved one or both renal artery ostia (but not those
of the superior mesenteric or celiac arteries) and
required suprarenal clamping and either reimplanta-
tion or bypass grafting of one or both renal arteries.
Patients with juxtarenal aneurysms not directly
involving the renal artery ostia, aortic pseudoa-
neurysms occurring above previous infrarenal
abdominal aortic aneurysm repairs, mycotic
aneurysms, and aneurysms related to arteritis were
specifically excluded from analysis. After exclusions,
165 patients were identified to have undergone 108
TAA (66%) and 57 SRA (34%) reconstructions. Of
the patients with TAAs, 53 had group IV aneurysms,
and 55 had group III aneurysms. Operations were
classified as nonelective if they were urgently per-
formed for aneurysm rupture or for symptomatic,
intact aneurysms within 24 hours of presentation.
The end point for survival analysis was defined as
death or recent follow-up within 6 months of study
closure. Follow-up was complete for 155 patients
(94%) at a median interval of 2.3 years (mean, 2.8
years; range, 0-10 years). Ten patients were lost to
follow-up after discharge from the hospital.
The study group consisted of 109 men and 56
women with a mean age of 70 years (median, 70
years; range, 29-89 years) at the time of their initial
operations. Mean aneurysm size was 6.9 cm (median,
6.5 cm; range 4.0-12.0 cm). There were 125
aneurysms (76%) repaired electively, whereas 40
repairs (24%) were nonelective (Table I). The etiolo-
gy of the aneurysm was degenerative in 153 patients
(93%) and dissection in 12 others (7%). Dissections
occurred in two patients with SRAs (4%), two
patients with group IV TAAs (4%), and eight patients
with group III TAAs (15%). Three of the patients
presenting with dissection had Marfan’s syndrome,
and 19 patients had family histories of aortic
aneurysm. Associated risk factors included hyperten-
sion in 135 patients (82%), hyperlipidemia in 52
(32%), cardiac disease in 88 (53%), chronic renal
insufficiency (serum creatinine > 1.5 mg/dL) in 50
(31%), pulmonary disease in 85 (53%), and a history
of stroke in 8 (5%). Of note, 119 patients (72%) were
smokers, whereas only six (4%) were diabetic.
For elective repairs, aneurysms were evaluated
with computed tomography and aortic angiography
or magnetic resonance imaging scans. Occlusive dis-
ease (> 50% stenosis) involved one or both renal
arteries in 48 patients (39%) and one or more mesen-
teric vessels in 71 patients (43%). There were 133
patients (81%) who had objective testing for coro-
nary artery disease (CAD) with thallium perfusion
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Table I. Clinical presentation and 30-day mortality
Nonelective repair
Elective repair Intact Ruptured Total
Aneurysm extent No. Deaths Percent No. Deaths Percent No. Deaths Percent No. Deaths Percent
Suprarenal 49 0 — 4 0 — 4 1 25 57 1 1.8
Group IV 38 4 11 4 0 — 11 2 22 53 6 11
Group III 38 5 13 9 0 — 8 6 75 55 11 20
Totals 125 9 7.2 17 0 — 23 9 39 165 18 11
scans (78) and/or cardiac catheterization (75); of
these patients, 65 had no serious CAD, whereas 68
others were found to have either ischemia or scar on
thallium scanning or > 50% coronary artery stenosis
by angiography. There were 35 patients who under-
went coronary revascularization before aneurysm
repair (percutaneous coronary angioplasty, seven;
coronary bypass graft surgery, 25; both, three). 
All 108 group III and group IV aneurysms were
repaired through use of the inclusion technique
through a left thoracoretroperitoneal exposure. Of
57 SRAs, 53 were approached through the left tho-
racoretroperitoneal exposure and the remaining 4 by
a retroperitoneal approach without a thoracic com-
ponent. No aneurysms in this series were repaired
transperitoneally. Cold renal perfusate (consisting of
Ringer’s lactate containing heparin [2000 U/L],
mannitol [18 g/L], and methylprednisolone [500
mg/L] chilled to 3˚C), mannitol, low-dose
dopamine, and furosemide were routinely used for
renal protection. Depending on the proximal extent
of the aneurysm, heparin anticoagulation, single
lung anesthesia, cerebrospinal fluid (CSF) drainage,
and preservation of patent lower intercostal or upper
lumbar arteries for spinal cord protection were used
at the discretion of the surgeon.
Operative deaths were defined as those occurring
within 30 days of aneurysm repair. Postoperative
complications were defined by the following criteria:
acute renal dysfunction (ARD) as a postoperative
serum creatinine value of at least 2.0 mg/dL and at
least 1.0 mg/dL greater than the preoperative value;
pulmonary failure as a prolonged postoperative intu-
bation period (> 48 hours) or the need for reintuba-
tion; myocardial infarction as an elevation of cardiac
isoenzymes or electrocardiographic evidence of
infarction. Hemorrhagic complications involved a
postoperative transfusion requirement of more than
4 units of packed red blood cells (pRBCs) or more
than 4 units of fresh frozen plasma (FFP) within the
first 24 hours.
The association between baseline variables and
early (30-day) morbidity and mortality was assessed
through use of the Fisher exact test, the χ2 test, or
logistic regression. Kaplan-Meier estimates of sur-
vival and 95% CIs at various time points were gener-
ated for the entire series as well as for subgroups
stratified according to aneurysm extent and the pres-
ence of either renal failure or a neurologic deficit at
discharge. The univariate association of baseline vari-
ables with survival was assessed with Cox propor-
tional hazards analysis. For each outcome, multivari-
able models were attempted when appropriate. A
significance level of P = .05 was used for each
hypothesis, and a Bonferroni correction to the sig-
nificance criterion was made for multiple compar-
isons. SAS statistical software (SAS Institute, Inc,
Cary, NC) was used for all analyses.
RESULTS
Early mortality 
For all 165 aneurysm procedures, there were 18
early (30-day) postoperative deaths (11% [95% CI,
7%-17%; Table I). All patients who died within 30
days postoperatively were still hospitalized at the
time of death. Four additional patients died before
hospital discharge (at 37, 38, 39, and 54 postopera-
tive days) for a predischarge mortality rate of 13%
(22/165). Causes of the 18 early (30-day) postop-
erative deaths were as follows: multisystem organ
failure, seven; cardiac events, four; hemorrhage,
four; pulmonary complications, one; renal complica-
tions, one; stroke, one. As indicated in Table II, the
postoperative mortality rate for 125 elective repairs
(7.2%) was significantly better than the rate for 40
nonelective repairs (23%; P = .016) and the rate for
the 23 patients whose aneurysms had ruptured
(39%; P = .001). The early postoperative mortality
rate also differed according to aneurysm extent (P =
.004 [overall]). The postoperative mortality rate of
1.8% (1/57) for patients who underwent SRA repair
was lower than that for those who had group IV
TAAs (11%; 6/53), but this apparent difference was
not statistically significant (P = .07). However, the
mortality rate after SRA repair was significantly
lower than that for patients having group III TAAs
(20%; 11/55; P = .013).
Early morbidity
There were 144 patients (87%), including the 18
patients who died in the early postoperative period,
who had one or more postoperative complications.
The relative incidence of all fatal and nonfatal post-
operative complications is illustrated in Fig 1. A total
of 32 patients (19%) required reoperations for com-
plications. The most common reoperation was tra-
cheostomy for pulmonary failure in 10 patients
(6%). Reoperation for retroperitoneal bleeding was
necessary in eight patients (5%) and was associated
with a significantly higher mortality rate (38%) in
these patients than in patients who did not require
reoperations for hemostasis (10%, P = .043). Four
patients (2%) required reoperations for thrombosis
of renal grafts (two) or femoral arteries (two),
whereas five patients (3%) had reoperations for gas-
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trointestinal complications, two for colon ischemia,
and three for cholecystitis. The remaining five reop-
erations (3%) were done because of infections or
wound complications.
Cardiac morbidity
Myocardial infarction (MI) occurred in five
patients (3.0%) and was directly responsible for one
early postoperative death (0.6%). Early postoperative
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Table II. Univariate association (by logistic regression analysis) with 30-day mortality rates
Odds ratio 
Variable Grouping N Deaths (%) (95% CI) P value
Age 10-y increment 165 18 (10.9) 1.43 (0.72, 2.9) .31
Sex Male 109 11 (10.1) 0.79 (0.29, 2.2) .64
Female 56 7 (12.5) 1.00
Diabetes Yes 7 1 (14.3) 1.38 (0.16, 12.2) .56
No 158 17 (10.8) 1.00
Hypertension Yes 135 15 (11.1) 1.13 (0.30, 4.2) .99
No 30 3 (10.0) 1.00
Chronic obstructive Yes 80 8 (10.0) 0.83 (0.31, 2.2) .72
pulmonary disease No 85 10 (11.8) 1.00
Tobacco use Yes 119 13 (10.9) 1.01 (0.34, 3.0) .99
No 46 5 (10.9) 1.00
Cardiac disease Yes 88 11 (12.5) 1.43 (0.53, 3.9) .48
No 77 7 (9.1) 1.00
Prior aortic surgery Yes 47 6 (12.8) 1.08 (0.27, 4.4) .63
No 118 12 (10.2) 1.00
Preoperative creatinine Yes 22 4 (18.2) 2.02 (0.60, 6.8) .25
≥ 2.0 mg/dL No 141 14 (9.9) 1.00
Dissection Yes 12 2 (16.7) 1.7 (0.34, 8.5) .53
No 153 16 (10.5) 1.0
Aneurysm type .004 overall*
Group IV 53 6 (11.3) 7.15 (0.83, 61.5) .22 vs group III
Group III 55 11 (20.0) 14.00 (1.7, 112.6) .013 vs SRA†
Suprarenal 57 1 (1.8) 1.00 .07 vs IV
Operative urgency Nonelective 40 9 (22.5) 3.74 (1.4, 10.2) .016*
Elective 125 9 (7.2) 1.00
Rupture Yes 23 9 (39.1) 9.50 (3.2, 27.9) <.001*
No 142 9 (6.3) 1.00
Total operative time 60-min increment 1.02 (0.78, 1.3) .88
Visceral clamp time 10-min increment 1.18 (0.94, 1.5) .16
Estimate blood loss 500-cc increment 1.04 (1.0, 1.1)) .003*
pRPBc 500-cc increment 1.17 (1.0, 1.3) <.001*
Platelets 500-cc increment 2.12 (1.3, 3.4) .002*
FFP 500-cc increment 1.20 (1.1, 1.3) .001*
Reoperation for bleed Yes 8 3 (37.5) 5.68 (1.2, 26.2) .043*
No 157 15 (9.6) 1.00
SCI Yes 10 3 (30.0) 4.00 (0.94, 17.1) .08
No 155 15 (9.7) 1.00
Stroke Yes 6 2 (33.3) 4.41 (0.75, 26.0) .13
No 157 16 (10.2) 1.00
MI Yes 5 3 (60.0) 14.50 (2.2, 93.8) <.001*
No 160 15 (9.4) 1.00
All cardiac complications Yes 47 9 (19.1) 2.87 (1.1, 7.8) .032*
No 118 9 (7.6) 1.00
Pulmonary failure Yes 40 11 (27.5) 6.39 (2.3, 17.9) <.001*
No 125 7 (5.6) 1.00
Pneumonia Yes 32 7 (21.9) 3.11 (1.1, 8.8) 0.51
No 133 11 (8.3) 1.00
Renal failure <.001 overall*
Yes—no dialysis 32 2 (6.3) 0.95 (0.19, 4.8) .007 vs 
failure-dialysis†
Yes—dialysis 23 9 (39.1) 9.18 (3.0, 28.6) <.001 vs 
no failure†
No failure 107 7 (6.5) 1.00 .95 vs failure-
no dialysis
*P < .05 significance overall.
†P < .017 significance with Bonferroni correction.
deaths occurred in a total of three patients who had
postoperative MIs (60%), a mortality rate signifi-
cantly higher than that for all other patients who did
not have postoperative MIs (9%; P < .001). Other
cardiac complications included congestive heart fail-
ure (CHF) in four patients (2.4%), atrial arrhythmias
in 34 patients (21%), and ventricular arrhythmias in
19 patients (12%); there were three deaths (1.8%).
Patients with any of these cardiac complications had
a significantly higher postoperative mortality rate
(19%) than did patients who had none of them
(7.6%; P = .032). Cardiac complications caused four
(22%) of the 18 early deaths, but no significant asso-
ciation was found in either the postoperative mor-
tality rates or the incidence of postoperative cardiac
complications among patients who had preoperative
clinical evidence of CAD and patients who did not
(Table II) or among those who underwent myocar-
dial revascularization. This comparison may be con-
founded by the fact that some form of myocardial
revascularization was done preoperatively in 35 of
the patients with the most serious CAD.
Renal morbidity
ARD occurred in 55 patients (34%) after
aneurysm repair; 23 of these patients (14%) required
dialysis, with 11 in-hospital deaths (48%). Seven
(58%) of the 12 surviving patients required only
temporary dialysis. Ten (8%) of the 125 patients who
underwent elective aneurysm repair required dialy-
sis; this compared with four (24%) of 17 patients
who required urgent operation for symptomatic but
intact aneurysms (P = .07) and nine (39%) of 23
patients with ruptured aneurysms (P < .001). For
elective operations only, dialysis was necessary in one
(2%) of 49 patients with SRAs; this compared with
nine (12%) of 76 patients with group III or group
IV TAAs (P = .09). The early postoperative mortali-
ty rate was significantly higher for patients who had
ARD (20%) than for those who did not (6.5%; P =
.010). However, the mortality rate for patients with
ARD who did not require dialysis (6%) was nearly
identical to that for patients with no ARD (7%; P =
.95). Only patients with a dialysis requirement had a
higher early mortality rate (39%; P < .001). 
Pulmonary morbidity
Forty patients (24%) had pulmonary failure, and
their postoperative mortality rate (28%; 11/40) was
significantly higher (P < .001) than the rate for
patients who did not have pulmonary failure (6%;
7/125). Pneumonia occurred in 32 patients (19%)
and was accompanied by a mortality rate of 22%
(7/32); this compared with a rate of 8% (11/133) for
patients without pneumonia (P = .051). Tracheostomy
was performed in 10 patients (6%) who required pro-
longed respiratory support (Table II). 
Neurologic morbidity
SCI occurred in 10 (6%) of the entire series of
165 patients, causing paraplegia in six patients (4%)
and paraparesis in four others (2%). All SCI events
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Fig 1. Complications among 165 patients who underwent suprarenal or group IV or group III TAA
repairs. Some patients had more than one complication. DVT, Deep venous thrombosis; PE, pul-
monary embolus; TAA, thoracoabdominal aortic aneurysm.
were observed in the early postoperative period and
were usually recognized when the patient was
awake enough to undergo neurologic examination.
SCI was associated with a substantial early mortali-
ty rate among patients with SCI in comparison with
those without SCI (30% vs 10%), but this difference
was not statistically significant (P = .08; Table II).
Six (5%) of the 125 patients who underwent elec-
tive aneurysm repair sustained SCI; this compared
with four (10%) of the 40 patients who had non-
elective operations (P = .26; Table III). SCI
occurred in three (25%) of the 12 patients with dis-
section and seven (5%) of the 153 patients with
degenerative aneurysms (P = .024). There were no
instances of SCI among patients with SRAs, and
only one patient with a group IV TAA (2%) became
paraplegic (after emergency repair of a ruptured
aneurysm that required 70 minutes of supraceliac
aortic clamping). Of all of the 55 patients who
underwent group III TAA repairs, however, SCI
occurred in nine (16%), with paraplegia in five of
these patients (9%) and paraparesis in four others
(7%). These risks were significantly higher than
those for SRA (P = .001) and group IV TAA pro-
cedures (P = .016; Table III). With respect to group
III TAA, SCI occurred in three of eight patients
presenting with dissection (38%) as well as in three
of eight (38%) with ruptured aneurysms. Two
patients had both dissecting and ruptured
aneurysms. Consequently, SCI occurred in four (all
paraplegia) of 14 patients with group III TAA
(29%) with either rupture or dissection and in five
(one paraplegia, four paraparesis) of 41 patients
(12%) with neither (P = .21).
Univariate and multivariable analyses 
Mortality. A number of factors were analyzed to
assess their possible association with the 30-day
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Table III. Univariate association (by logistic regression analysis) with SCI
Variable Grouping N No. of SCIs (%) OR (95% CI) P value
Age 10-y increment 165 1.15 (0.50, 2.6) .75
Sex Male 109 4 (3.7) 0.32 (0.09, 1.2) .09
Female 56 6 (10.7) 1.00
Diabetes Yes 7 1 (14.3) 2.76 (0.30, 25.4) .36
No 158 9 (5.7) 1.00
Hypertension Yes 135 7 (5.2) 0.49 (0.12, 2.0) .39
No 30 3 (10) 1.00
Chronic obstructive Yes 78 5 (6.4) 1.10 (0.31, 3.9) .99
pulmonary disease No 85 5 (5.9) 1.00
Tobacco use Yes 119 8 (6.7) 1.59 (0.32, 7.8) .73
No 46 2 (4.3) 1.00
Cardiac disease Yes 88 5 (5.7) 0.87 (0.23, 3.1) .99
No 77 5 (6.5) 1.00
Prior aortic surgery Yes 47 3 (6.4) 1.08 (0.27, 4.4) .99
No 118 7 (5.9) 1.00
Preoperative creatinine Yes 22 2 (9.1) 1.67 (0.33, 8.4) .63
≥ 2.0 mg/dL No 141 8 (5.7) 1.00
Dissection Yes 12 3 (25.0) 7.0 (1.5, 31.5) .024*
No 153 7 (5.0) 1.00
Aneurysm type <.001 overall*
Group IV 53 1 (1.9) .016 vs group III†
Group III 55 9 (16.4) .001 vs suprarenal†
Suprarenal 57 0 (0.0) .48 vs group IV
Operative urgency Nonelective 40 4 (10.0) 2.24 (0.59, 8.2) .26
Elective 125 6 (4.8) 1.00
Rupture Yes 23 4 (17.4) 4.77 (1.2, 18.5) .034*
No 142 6 (4.2) 1.00
Total operative time 60-min increment 1.26 (0.87, 1.8) .23
Visceral clamp time 10-min increment 1.29 (1.0, 1.6) .043*
Estimated blood loss 500-cc increment 1.03 (1.0, 1.1) .015*
pRBCs 500-cc increment 1.07 (1.0, 1.1) .06
Platelets 500-cc increment 2.33 (1.3, 4.2) .005*
FFP 500-cc increment 1.12 (1.0, 1.3) .08
CSF drainage Yes 96 7 (7.3) 2.44 (0.49, 12.1) .32
No 64 2 (3.2) 1.00
*P < .05 significance overall.
†P < .017 significant with Bonferroni correction.
mortality rate (Table II). With the exceptions of
aneurysm type and urgency of repair, no preopera-
tive factors (including age, cardiopulmonary disease,
and renal insufficiency creatinine ≥ 2.0) were signif-
icantly associated with early mortality. Significant
intraoperative predictors of early death were estimat-
ed blood loss (P = .003) and increasing transfusion
requirements for pRBCs (P < .001), platelets (P =
.002), and FFP (P = .001).
A multivariable logistic regression model consid-
ering all preoperative and intraoperative factors
yielded aneurysm rupture (P = .002), extent of
aneurysm (P = .045), and transfusion requirement
for pRBCs (P = .008) as independent predictors of
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Table IV. Multivariable analyses (by logistic regression analysis with backward selection) of 30-day mortality
Analysis Variable OR (95% CI) P value
Preoperative and intraoperative Rupture 7.1 (2.0, 25.0) .002
factors considered together pRBCs 1.12 (1.03, 1.21) .008
Aneurysm extent .045
Suprarenal 1.0
Group IV 6.3 (0.61, 64.9) .12 vs SRA
Group III 10.4 (1.08, 99.8) .043 vs SRA
Preoperative, intraoperative, and Rupture 7.9 (2.2, 29.1) .002
postoperative factors pRBCs 1.16 (1.06, 1.26) .001
considered together Postoperative MI 30.6 (3.8, 246.7) .001
Table V. Univariate association (by logistic regression analysis) with ARD
Variable Grouping N ARD OR (95% CI) P value
Age 10-y increment 162 1.2 (0.80, 1.8) .38
Diabetes Yes 7 5 5.2 (0.98, 28.0) .045*
No 155 50 1.0
Hypertension Yes 132 48 1.9 (0.75, 4.7) .16
No 30 7 1.0
Creatinine ≥ 2.0 mg/dL Yes 22 14 4.2 (1.6, 10.8) .003*
No 140 41 1.0
Cardiac disease Yes 86 35 1.9 (0.99, 3.7) .052
No 76 20 1.0
Aneurysm type Suprarenal 57 12 1.0 .009 vs group IV†
Group IV 51 23 3.1 (1.3, 7.2) .40 vs group III
Group III 54 20 2.2 (0.95, 5.1) .07 vs suprarenal
Operative urgency Nonelective 38 25 6.0 (2.7, 13.2) <.001*
elective 124 30 1.0
Rupture Yes 21 13 3.8 (1.5, 9.9) .005*
No 141 42 1.0
Dissection Yes 12 6 2.1 (0.63, 6.7) .34
No 150 49 1.0
Renal occlusive disease Yes 46 17 2.5 (1.1, 5.7) .029*
No 79 15 1.0
Visceral clamp time 10-min increment 1.07 (0.92, 1.3) .37
Renal endarterectomy Yes 92 32 1.1 (0.59, 2.2) .70
or bypass graft No 69 22 1.0
Estimated blood loss 500-cc increment 1.01 (0.99, 1.04) .20
pRBCs 500-cc increment 1.05 (1.0, 1.1) .06
Platelets 500-cc increment 1.6 (1.1, 2.4) .009*
FFP 500-cc increment 1.1 (1.02, 1.2) .017*
Reoperation for bleed Yes 8 7 15.5 (1.8, 129) .002*
No 154 48 1.0
All cardiac complications Yes 46 20 1.8 (0.88, 3.6) .11
No 116 35 1.0
Pulmonary failure Yes 39 26 6.5 (3.0, 14.2) <.001*
No 123 29 1.0
*P <.05 significance overall.
†P < .07 significance with Bonferroni correction.
early death (Table IV). When all postoperative fac-
tors were considered in the multivariable model, the
independent predictors of 30-day death were
aneurysm rupture (P = .002), transfusion require-
ment for pRBCs (P = .001), and a postoperative MI
(P = .001).
Morbidity. Univariate analysis of factors associ-
ated with ARD for 162 patients for whom both pre-
operative and postoperative creatinine values were
available is summarized in Table V. Preoperative pre-
dictors of ARD were diabetes (P = .045), group III
or group IV TAA (P = .009), nonelective operation
(P < .001), aneurysm rupture (P = .005), and the
presence of preexisting renal artery occlusive disease
(P = .029). Intraoperative factors associated with
ARD were increasing transfusion requirements for
platelets (P = .009) and FFP (P = .017). The mean
suprarenal clamp time was 53 minutes; this was not
found to be associated with ARD (P = .37).
Although 39% of patients had renal artery stenosis,
neither renal endarterectomy (28 patients) nor
bypass grafting (86 patients) was found to be associ-
ated with ARD (P = .70). Postoperative factors asso-
ciated with ARD were reoperation for bleeding (P =
.002) and pulmonary failure (P < .001). When pre-
operative, intraoperative, and postoperative factors
were considered, a multivariable model for ARD
yielded only the urgency of operation and the devel-
opment of pulmonary failure as significant indepen-
dent predictors of ARD (P < .001).
Univariate analysis of factors associated with SCI
is summarized in Table III. The risk of having post-
operative SCI was higher among patients presenting
with aneurysm rupture (17.4% vs 4.2%; P = .034)
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Fig 2. Cumulative overall survival (Kaplan-Meier method; 95% CIs) for entire series of 165
patients. 
Fig 3. Cumulative survival (Kaplan-Meier method; 95% CIs): patients with and without ARD
vs patients requiring postoperative dialysis.
and/or aortic dissection (25.0% vs 5.0%; P = .027),
but no other preoperative factors were significantly
associated with spinal cord complications.
Intraoperative factors associated with SCI were
incremental increases in suprarenal aortic cross-
clamp time (P = .043), estimated blood loss (P =
.015), and the transfusion requirement for platelets
(P = .005). There was a suggestion of a higher like-
lihood of SCI for patients with higher transfusion
requirements for pRBCs (P = .06) and FFP (P =
.08), but the associations were not statistically sig-
nificant. We did not observe a significant difference
in the likelihood of SCI in patients treated with
(7.3%) and without (3.1%) CSF drainage (P = .32).
Late survival. Including the 18 early (30-day)
deaths, a total of 64 patients had died by the time of
study closure. The Kaplan-Meier survival estimates
for the entire series were 71% (95% CI, 64%-79%) at
3 years and 50% (95% CI, 40%-60%) at 10 years (Fig
2). Cardiac complications were responsible for eight
(17%) of the 46 late deaths, pulmonary causes for
nine (20%), strokes for two (4%), renal failure for
three (7%), and miscellaneous events for nine (20%).
The cause of late death was unknown in 15 patients
(32%). Postoperative ARD requiring dialysis was
associated with a decreased late survival rate (P <
.001; Fig 3). Whereas the survival experience for
patients without postoperative ARD (5-year sur-
vival, 56%) was not significantly different from that
for patients with ARD who did not require dialysis
(5-year survival, 49%), only an estimated 13% of the
patients for whom dialysis was necessary survived 5
years (P < .001). Neither the extent of aneurysm
repair (P = .46) nor the complication of SCI (P =
.40) was significantly associated with late survival.
Likewise, we did not find a significant association
between late survival and the presence of CAD or
myocardial revascularization among patients with
CAD (P = .83) in this small series of patients.
DISCUSSION
The natural history of untreated SRAs and TAAs
is poor, the reported 5-year survival estimates rang-
ing from 13% to 46%.5 Early attempts to repair these
complex aneurysms were associated with substantial
mortality risk, often as high as 50%.1,6 With the
development of the inclusion technique by
Crawford,2 the perioperative mortality rate, as well
as the rates of paraplegia and renal failure, substan-
tially declined. Despite this advance, however, the
mortality rate of 8% and morbidity rates from SCI
(16%) and renal failure requiring dialysis (9%) are
still substantial for the more extensive aneurysms.7
To decrease the risk of renal failure and SCI, some
investigators have advocated the use of various
adjuncts, including atriofemoral or femorofemoral
bypass graft and spinal cord cooling techniques, for
extensive group I and group II TAAs3,4,8,9; howev-
er, this has not been universally advocated for less
extensive aneurysms. Because of coagulation, cannu-
lation, and embolization problems that can be asso-
ciated with cardiopulmonary bypass, many surgeons
continue to repair group III and group IV TAAs
without adjunctive cardiopulmonary bypass mea-
sures. Our analysis focused on the preoperative and
perioperative factors that influenced the results of
suprarenal and low thoracoabdominal aortic
aneurysm repair in four areas: the 30-day mortality
rate, the early complication of renal dysfunction, the
early complication of SCI, and late survival. 
Early mortality rates. In our experience, the
30-day mortality rates for elective and nonelective
repair of group III and group IV TAAs (16%) and
SRAs (2%), as well as the 5-year survival rate (50%),
are consistent with the rates reported in many con-
temporary series7,9-14 and justify the repair of these
aneurysms when they become sufficiently large.
Early mortality rates were influenced by the urgency
and extent of aneurysm repair. Unlike some
reports,13 our review did not demonstrate an associ-
ation between other preoperative factors (age, sex,
or the presence of diabetes, hypertension, pul-
monary or cardiac disease, renal insufficiency, or aor-
tic dissection) and the early postoperative mortality
risk, perhaps because of sample size. Nevertheless,
like others, we attempt to optimize these comor-
bidities preoperatively when feasible.
Intraoperative factors associated with a higher
early mortality rate were increasing blood loss and
transfusion requirements for blood and coagulation
factors. Similarly, postoperative bleeding requiring
reoperation was also significantly associated with the
early mortality rate. Although these factors are related
to the development of coagulopathy associated with
urgent operation and rupture, they may also be
caused by hypothermia, hemodilution, or the devel-
opment of a fibrinolytic state due to visceral
ischemia.15 Some authors have advocated intraopera-
tive visceral perfusion15; in our series, however, pro-
longed visceral clamp times were not significantly
associated with higher early mortality rates (P = .16),
an observation also reported by others,7,16
Nevertheless, we attempt to reduce coagulopathy risk
by minimizing clamp times, the preemptive transfu-
sion of FFP and platelets early in the operation, and
aggressive warming of fluids and ventilator gasses. 
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We found that the development of postoperative
cardiac, pulmonary, and renal complications was
associated with increased early mortality rates for
patients after aneurysm repair, an observation also
reported by others.7,14,16 Although fatal arrhythmias
(2%) and postoperative MIs (3%) were uncommon,
these cardiac complications were frequently associat-
ed with early death. We found apparent increases in
perioperative cardiac events and early mortality rates
for patients with and patients without clinical CAD,
respectively, but these differences were not statisti-
cally significant. Although we have reported that
coronary revascularization benefits late survival after
infrarenal aneurysm repair in nondiabetic men,17,18
in this small series we did not demonstrate signifi-
cant differences in perioperative or long-term sur-
vival for patients with more extensive aneurysms.
As reported by others,5,16,19 the leading causes
of early postoperative death after TAA and SRA
repair were hemorrhage and cardiac complications
initially; these were followed by renal and pul-
monary failure leading to multisystem organ failure
later in the early postoperative period. Inasmuch as
nearly one quarter of the operations in this series
(24%) were urgent and the early mortality rate for
ruptured complex aneurysms was 39%, the overall
mortality rates for both elective and nonelective
repair of group IV (11%) and group III (20%) TAAs
were consistent with those in other reports, which
ranged from 0% to 28% and 4% to 33%, respective-
ly.7,14,20-24
Acute renal dysfunction. The preoperative fac-
tors that we found to be associated with ARD
included preexisting diabetes, creatinine elevation by
more than 2 mg/dL, renal occlusive disease,
aneurysm extent, operative urgency, and aneurysm
rupture. Perioperative factors included increasing
blood loss, blood factor requirement, and postoper-
ative pulmonary failure. Multivariate analysis yielded
urgency and pulmonary failure as independent vari-
ables associated with the development of ARD.
Although preexisting creatinine elevation and the
presence of renal artery stenosis were each associat-
ed with an increased likelihood for ARD, the perfor-
mance of renal bypass grafting or endarterectomy
was not associated with ARD. This finding may
reflect the protective effect of the reconstruction;
alternatively, it may indicate that many of these pro-
cedures were left renal bypass grafts performed in
the absence of renal occlusive disease but necessary
because of involvement of the left renal artery by the
aneurysm. The extent of suprarenal clamp time was
not associated with ARD in our series, and its rela-
tionship to ARD has also been inconsistent in other
reports.7,11,25,26 This observation may represent the
beneficial effect of the cold renal perfusate infusion
used with most patients in our series. Distal aortic
perfusion was not used for any of our repairs, and its
role has generally been controversial.3,7 The propor-
tion of patients requiring dialysis after SRA and TAA
repair in our current series (14%) compares favorably
with that described in our earlier report (27%)14 and
is consistent with the 9% to 15% reported by oth-
ers.3,7,27-30 Nevertheless, ARD remains a serious
complication, because the need for dialysis appears
to significantly increase the early mortality risk (48%)
and to erode the 5-year survival estimate (13%), an
observation also reported by others.3,7,13,25
SCI. We found that the preoperative factors sig-
nificantly associated with the development of SCI
were aneurysm extent, aneurysm rupture, and aortic
dissection, all of these features being consistent with
those noted in other reports.7,13,16,19 Intra-
operatively, the risk for SCI is associated with
increasing suprarenal aortic crossclamp time, blood
loss, and platelet transfusion requirements. The inci-
dence of SCI in our series is comparable with that in
other reports,7,8,11,19,27 which also have document-
ed a very low risk of SCI with SRA (0%) and group
IV TAA (2%) repairs but a significantly increased risk
for group III TAA repairs (16%). Because 14 (26%)
of the 55 patients with group III TAA in our series
had either ruptured or dissecting aneurysms, our
population includes a substantial number of patients
who are at particularly high risk for SCI. With one
exception, all instances of SCI occurred among the
group III TAA repairs. We did not demonstrate a
reduction in SCI by the use of CSF drainage for
these lower TAAs, and this may be a function of
small sample size. However, in a randomized,
prospective series of higher-risk group I and group
II TAAs, Crawford et al31 also failed to demonstrate
a statistically significant reduction in the paraplegia
rate with the use of CSF drainage. Although lower
intercostal arteries generally were reimplanted in our
series, it was not possible retrospectively to collect
reliable data for analysis. Enthusiasm concerning the
effectiveness of intercostal artery reattachment in
preventing paraplegia has varied.7,8,13,21 Currently,
we advocate preservation of patent lower thoracic
intercostal arteries and the use of CSF drainage
when feasible, though our data do not prove the
effectiveness of these measures.
Some advocate the use of distal perfusion for
group I and group II TAAs for spinal cord preserva-
tion, but its role in repair of lower TAAs is less clear.4
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In a series of 164 patients who underwent repair of
group III TAAs, Safi et al8 reported no neurologic
deficits among patients treated with the adjuncts of
CSF drainage and distal aortic perfusion; this com-
pared with a 20% incidence among patients treated
without these precautions. Using an uncomplicated
aortic crossclamp technique, however, Crawford et
al13 reported an equally impressive 3% incidence of
SCI in a series of 157 group III TAA repairs.
Alternatively, others have proposed the use of the
uncomplicated cross-clamp technique combined
with adjunctive epidural cooling, reporting an inci-
dence of SCI of 3%; this compared with 23% for
patients without epidural cooling (P < .001).9
In conclusion, aneurysms involving the suprarenal,
visceral, and lower thoracic aorta may be repaired with
acceptable perioperative mortality and late survival
rates. Although late survival was unfavorably influ-
enced by the requirement for postoperative dialysis, we
did not demonstrate significant associations between
late survival and the presence of CAD or SCI or the
extent of the aneurysm. The risk of SCI is increased for
patients with aortic dissection and may be stratified
according to the proximal extent of the aneurysm. The
role of epidural cooling and distal perfusion in the
treatment of these aneurysms remains to be defined,
but these adjuncts may have application in the man-
agement of group III TAAs.
Becky Roberts maintains our departmental registry
and assisted in data collection.
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